欧州のアクション・プラン

欧州議会でアクション・プランが採択された．法的拘束力はなく，決意表明のようなもの（European Parliament resolution on nanosciences and nanotechnologies: an action plan for Europe 2005-2009）．ナノテクの社会的影響に関する項目は19〜26あたり．

19. Stresses that the technological risks posed (from conception to disposal or recycling) to human health, consumers, workers and the environment must be assessed throughout the life cycle of nanoscience and nanotechnology products;

製品のライフサイクルにわたってリスク評価すべき，という勧告．

20. Recommends that lists of ingredients in consumer products identify the addition of manufactured nanoparticulate material;

消費者製品の成分リストに工業ナノ材料を加えよ，という勧告．

21. Emphasises the need to respect high ethical principles and welcomes the planned reviews on issues such as non-therapeutic human enhancement and links between nanosciences and nanotechnologies and individual privacy; expects the reviews to be public and to include a thorough analysis of nanomedicine;

ヒトの能力増強（Human enhancement）やプライバシーに関する倫理的問題を調査し対処せよ，という勧告．

22. Supports the setting up of ethical committees which, by providing independent scientific advice, will help ensure that the public is properly informed and help create a climate of trust based on awareness of the possible risks and benefits associated with the use of discoveries in the field of nanotechnologies;

倫理委員会を設立せよ，という勧告．

23. Welcomes the consultation conducted for this proposal and encourages the Commission to continue improving its work in order to respond to the increasing demand for better regulation;

ここに初めて「規制」という言葉がでてくる．「より良い規制を求める声が増し続けていることにに答えるために，欧州委員会が作業を続けることを奨励する」とのこと．

25. Calls on industry to share in the joint effort and urges it to participate in developing nanotechnologies, taking into account their wider economic, societal, health, safety and environmental effects and acting in accordance with the principles of corporate social responsibility; in this regard, stresses that businesses should help disseminate objective information about scientific discoveries in the nanoscience and nanotechnologies field, about their intended uses, their risks and benefits for society;

事業者への要求．使用目的や社会へのリスクとベネフィットを含んだ客観的な情報を公開することは，企業の社会的責任であると．

28. Emphasises that understanding of the potential damage to health and the environment of new, synthetic nanoparticles is still limited and that, consequently, the effects of nanoparticles that are not readily soluble or biodegradable should be investigated, in accordance with the precautionary principle, before such particles are put into production and placed on the market;

「予防原則」という言葉が出てくる．容易に溶けず，生分解しないナノ材料の影響はまだよく分かっていないので，市場に出回る前によく調査されるべきだ，と．